863 related articles for article (PubMed ID: 27496729)
1. Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion.
Bengsch B; Johnson AL; Kurachi M; Odorizzi PM; Pauken KE; Attanasio J; Stelekati E; McLane LM; Paley MA; Delgoffe GM; Wherry EJ
Immunity; 2016 Aug; 45(2):358-73. PubMed ID: 27496729
[TBL] [Abstract][Full Text] [Related]
2. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
[TBL] [Abstract][Full Text] [Related]
3. Role of PD-1 during effector CD8 T cell differentiation.
Ahn E; Araki K; Hashimoto M; Li W; Riley JL; Cheung J; Sharpe AH; Freeman GJ; Irving BA; Ahmed R
Proc Natl Acad Sci U S A; 2018 May; 115(18):4749-4754. PubMed ID: 29654146
[TBL] [Abstract][Full Text] [Related]
4. Transcription Factor IRF4 Promotes CD8
Man K; Gabriel SS; Liao Y; Gloury R; Preston S; Henstridge DC; Pellegrini M; Zehn D; Berberich-Siebelt F; Febbraio MA; Shi W; Kallies A
Immunity; 2017 Dec; 47(6):1129-1141.e5. PubMed ID: 29246443
[TBL] [Abstract][Full Text] [Related]
5. The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection.
Staron MM; Gray SM; Marshall HD; Parish IA; Chen JH; Perry CJ; Cui G; Li MO; Kaech SM
Immunity; 2014 Nov; 41(5):802-14. PubMed ID: 25464856
[TBL] [Abstract][Full Text] [Related]
6. 4-1BB signaling synergizes with programmed death ligand 1 blockade to augment CD8 T cell responses during chronic viral infection.
Vezys V; Penaloza-MacMaster P; Barber DL; Ha SJ; Konieczny B; Freeman GJ; Mittler RS; Ahmed R
J Immunol; 2011 Aug; 187(4):1634-42. PubMed ID: 21742975
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection.
Gabriel SS; Tsui C; Chisanga D; Weber F; Llano-León M; Gubser PM; Bartholin L; Souza-Fonseca-Guimaraes F; Huntington ND; Shi W; Utzschneider DT; Kallies A
Immunity; 2021 Aug; 54(8):1698-1714.e5. PubMed ID: 34233154
[TBL] [Abstract][Full Text] [Related]
8. Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion.
Ahn E; Youngblood B; Lee J; Lee J; Sarkar S; Ahmed R
J Virol; 2016 Oct; 90(19):8934-46. PubMed ID: 27466420
[TBL] [Abstract][Full Text] [Related]
9. Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1
Hudson WH; Gensheimer J; Hashimoto M; Wieland A; Valanparambil RM; Li P; Lin JX; Konieczny BT; Im SJ; Freeman GJ; Leonard WJ; Kissick HT; Ahmed R
Immunity; 2019 Dec; 51(6):1043-1058.e4. PubMed ID: 31810882
[TBL] [Abstract][Full Text] [Related]
10. CD8
Spiteri AG; Suprunenko T; Cutts E; Suen A; Ashhurst TM; Viengkhou B; King NJC; Hofer MJ
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543756
[TBL] [Abstract][Full Text] [Related]
11. On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection.
Richter K; Agnellini P; Oxenius A
Int Immunol; 2010 Jan; 22(1):13-23. PubMed ID: 19880580
[TBL] [Abstract][Full Text] [Related]
12. Polymicrobial Sepsis Increases Susceptibility to Chronic Viral Infection and Exacerbates CD8+ T Cell Exhaustion.
Condotta SA; Khan SH; Rai D; Griffith TS; Badovinac VP
J Immunol; 2015 Jul; 195(1):116-25. PubMed ID: 25980007
[TBL] [Abstract][Full Text] [Related]
13. Exhausted CD8
Sandu I; Cerletti D; Claassen M; Oxenius A
Nat Commun; 2020 Sep; 11(1):4454. PubMed ID: 32901001
[TBL] [Abstract][Full Text] [Related]
14. Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8(+) Cytolytic T Cell Responses.
Taylor A; Harker JA; Chanthong K; Stevenson PG; Zuniga EI; Rudd CE
Immunity; 2016 Feb; 44(2):274-86. PubMed ID: 26885856
[TBL] [Abstract][Full Text] [Related]
15. Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic lymphocytic choriomeningitis virus (LCMV), thereby circumventing LCMV-induced downregulation of costimulatory GITR ligand on APC.
Clouthier DL; Zhou AC; Watts TH
J Immunol; 2014 Nov; 193(10):5033-43. PubMed ID: 25281716
[TBL] [Abstract][Full Text] [Related]
16. Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells.
Odorizzi PM; Pauken KE; Paley MA; Sharpe A; Wherry EJ
J Exp Med; 2015 Jun; 212(7):1125-37. PubMed ID: 26034050
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion.
Blackburn SD; Crawford A; Shin H; Polley A; Freeman GJ; Wherry EJ
J Virol; 2010 Feb; 84(4):2078-89. PubMed ID: 19955307
[TBL] [Abstract][Full Text] [Related]
18. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection.
Penaloza-MacMaster P; Kamphorst AO; Wieland A; Araki K; Iyer SS; West EE; O'Mara L; Yang S; Konieczny BT; Sharpe AH; Freeman GJ; Rudensky AY; Ahmed R
J Exp Med; 2014 Aug; 211(9):1905-18. PubMed ID: 25113973
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells.
West EE; Jin HT; Rasheed AU; Penaloza-Macmaster P; Ha SJ; Tan WG; Youngblood B; Freeman GJ; Smith KA; Ahmed R
J Clin Invest; 2013 Jun; 123(6):2604-15. PubMed ID: 23676462
[TBL] [Abstract][Full Text] [Related]
20. PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis.
Zinselmeyer BH; Heydari S; Sacristán C; Nayak D; Cammer M; Herz J; Cheng X; Davis SJ; Dustin ML; McGavern DB
J Exp Med; 2013 Apr; 210(4):757-74. PubMed ID: 23530125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
